PRX003

DRUG2 trials

Sponsors

Prothena Biosciences Limited

Conditions

Psoriasis

Phase 1

Single Ascending Dose Study of PRX003 in Healthy Subjects

CompletedNCT02458677

Prothena Biosciences LimitedPsoriasis

Start: 2015-05-31End: 2016-02-29Updated: 2016-03-16

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

CompletedNCT02630901

Prothena Biosciences LimitedPsoriasis

Start: 2016-03-17End: 2018-02-28Updated: 2018-05-04